Return to CBI Antibody Core Home Page
  Return to other mammals list
    Return to Norway rat (Rat) ( Rattus norvegicus ) list


Norway rat (Rat) ( Rattus norvegicus )
Desmuslin


Links to multiple antibodies on this page for Desmuslin:
Desmuslin-pep1
Desmuslin
Desmuslin-pep2


Western result: +
control
Desmuslin-pep1
A0554
(fragment)

N.A. kDa (recombinant)
The western blot contains a test lane of ~20ug of a total protein extract from E coli with ~50ng to 500ng of the antigen (recombinant fusion protein containing a His tag). The negative control lane is the same except it contains ~50ng to 100 ng of a recombinant fusion protein of an irrelevant antigen. The blot was probed with a final antisera dilution of 1:1,000. The secondary antibody (Rabbit anti-mouse IgG + IgM, (H+L) horseradish peroxidase conjugated (Pierce)) is used at 1:5,000 dilution. Note, the molecular weight of the band on the western blot does not correspond to the molecular weight of the natural protein because only a fragment of the gene is used.

Antibody Name/Abbreviation: Desmuslin-pep1
CBI Antibody Core Code: A0554

"Lot" Number: 1 Position: 14(1142-1155)
% Identical Homology of Target to Mouse Protein: 0%
Molecular Weight of GST-fusion: N.A. KDa

Target sequence used to make this antibody:
GPTSPVVEMGVSDT







Western result: ++
GST
GST-Desmuslin
A0553
(fragment)

N.A. kDa (recombinant)
The western blot contains a test lane of ~20ug of a total protein extract from E coli with ~50ng to 500ng of the antigen (GST-antigen fusion protein). The negative control lane is the same except it contains ~50ng to 100 ng of a GST fusion protein of an irrelevant antigen. The blot was probed with a final antisera dilution of 1:1,000. The secondary antibody (Rabbit anti-mouse IgG + IgM, (H+L) horseradish peroxidase conjugated (Pierce)) is used at 1:5,000 dilution. Note, the molecular weight of the band on the western blot does not correspond to the molecular weight of the natural protein because only a fragment of the gene is used and it is fused to GST.

Antibody Name/Abbreviation: Desmuslin
CBI Antibody Core Code: A0553

"Lot" Number: 1 Position: 100(790-889)
% Identical Homology of Target to Mouse Protein: 85% (NP_997546.1| desmuslin isoform M)
Molecular Weight of fusion protein: N.A. KDa

Target sequence used to make this antibody:
ETHMAFSMHQRQRTNQPQVNVPHVEEVTEAGDSEGEQSYF
VSTPDEYPGGHDREDDGSVYGQIHIEEESTIRYSWQDEIA
QGTWRRKARGDTGEEKHMKV







Western result: +/-
control
Desmuslin-pep2
A0562
(fragment)

N.A. kDa (recombinant)
The western blot contains a test lane of ~20ug of a total protein extract from E coli with ~50ng to 500ng of the antigen (recombinant fusion protein containing a His tag). The negative control lane is the same except it contains ~50ng to 100 ng of a recombinant fusion protein of an irrelevant antigen. The blot was probed with a final antisera dilution of 1:1,000. The secondary antibody (Rabbit anti-mouse IgG + IgM, (H+L) horseradish peroxidase conjugated (Pierce)) is used at 1:5,000 dilution. Note, the molecular weight of the band on the western blot does not correspond to the molecular weight of the natural protein because only a fragment of the gene is used.

Antibody Name/Abbreviation: Desmuslin-pep2
CBI Antibody Core Code: A0562

"Lot" Number: 2 Position: 28(1135-1162)
% Identical Homology of Target to Mouse Protein: 78% (NP_997546.1| desmuslin isoform M)
Molecular Weight of GST-fusion: N.A. KDa

Target sequence used to make this antibody:
TEQVSYGGPTSPVVEMGVSDTRAIRSWT






Sequence Name: Desmuslin
Full name:
UniGene Number: Rn.46362
Accession Number: NM_182737
Source organism: Norway rat (Rat) ( Rattus norvegicus )
Full length size (aa): 1255
NCBI information page: click here

Full length sequence:
MLSWRLQTSSEKAELQELNARLYEYVCRVRELERENLLLEEELRSRLSRE
DRWAEDQALYAEEARSLRQQLDELSWSTALAEGERDALRRELLDLQREGL
EASTARGRLDAELEAQRRELEEALGARAALEALLGRLEAERRDLDAAHER
QVRELRARASSLTMHFRARATGPAAPPPRLRDVHDSYALLVAESWRESMQ
LYEDEVRELEQALRRGQESRLQAEDEARLCAQEADALRNQALELEQLRAR
LEDELLRMREEYGMQAEERQRVIDSLEDEKDALTLAMADRLREYQELLQV
KTGLSLEVATYRALLEGESNPEILIWTENIENVPRESRNTSYRYTDSVLQ
RKNEKNLFPRRKTPWAAVNHSSTLYSNGPGHLDSQTTTAVGNAARRGFLT
SCYSSSATTSQQKPLEKTVSSQASLRPVIPTHGFLRNTDAQVKTFSHGTK
AEGMGDTLTRRATESVITRESYRGHQGNVAAGAVNSTQSNERTVILGKKL
ETQATKEQERDRSGVVKLKPEEKMFDSKEKASEERNLRWEELTKLDARER
ESQHLRNEAKGKETLTGRSRKEREVPISLEVSRGSKSEVSTIHLQSSGRK
DSANSREREVKTKETKFHLDGKDTAGSLQSDSTTETIAENIVTTILKQFT
QSPGAEENVSSLPDTKVTYLDRKEFPGDRKTKTEIVVESKLTEDVDVSDE
AGLDYLLSKDVKEVGLKGKSTETVIGEMINLGLKGREGRAKVVNVEIVEE
PMSYVGGGKVEFSTPFQVEEVDDVSPSPKGFIEEEEGEGETHMAFSMHQR
QRTNQPQVNVPHVEEVTEAGDSEGEQSYFVSTPDEYPGGHDREDDGSVYG
QIHIEEESTIRYSWQDEIAQGTWRRKARGDTGEEKHMKVLEVPSASLGGA
FGSAHVKEEASGELHAEPTIIEKEIKIPHEFHTSIKGVFSSEPRHQLVEV
IGQLEETLPERMKEELSALTRQSQGEPGSVSVDVKKVQSSAGGSVTLMAE
VNLSQTVDADQLDLEELSRDEAGEIEKAVESVVRESLTKRSSPVPRSPDR
EDGEEAPAGGFLFKRWATRELYSPSGEKDDTDRVFHSSDQRVTQGPVSAT
VEVTSPTGFVQSHVLEDVSQSVRHVKLGPTEMWRTEQVSYGGPTSPVVEM
GVSDTRAIRSWTRDTGSEVEAHSVSHHGGWRVAHSRDEQSASTSSQASAG
DAHQARGEKGTEQAGFDKTVQLQRMVDQRSVASDEKKVALLYLDNEEEEE
GEGWF





Questions? Click here for answers.


© Monday, February 16, 2009 by the CBI Antibody Core and the Center for Biomedical Inventions, University of Texas Southwestern Medical School.